All In FutureTech Alliance Denies Allegations of False Acquisition of HyalRoute Communication Group
All In FutureTech Alliance (Nasdaq: AIFA), a Nasdaq-listed technology firm, has officially denied claims by former executives of HyalRoute Communication Group that its May 2026 announcement of acquiring a controlling stake in the company was “false” or “fabricated,” according to a statement released June 13, 2026. The dispute centers on a $400 million deal to secure over 70% of HyalRoute’s shares, with AIFA asserting the transaction adheres to legal and regulatory standards.
AIFA Denies Allegations of False Acquisition
AIFA stated in a press release that claims by former HyalRoute executives “directly contradict verified facts” and “undermine the legal rights of legitimate shareholders.” The company emphasized that the May 22, 2026, acquisition was conducted through formal negotiations with registered shareholders, including entities like Rainman Network and Dece Capital. “The transaction is based on documented agreements with verified shareholders, not individual claims by former management,” the statement read.
Some HyalRoute executives have reportedly criticized the deal via Cambodian media, alleging it was “manipulated” to exclude current leadership. AIFA dismissed these assertions, stating, “Such statements misrepresent the transaction’s scope and confuse shareholder-level agreements with corporate governance matters.”
Details of the Shareholding Transaction
The acquisition, valued at $400 million, involves purchasing shares at $10 per unit, with HyalRoute’s total enterprise value estimated at $4 billion. AIFA noted the deal followed “three years of negotiations” and is pending regulatory approvals. The company also mentioned support from certain state-owned shareholders, though specific names were not disclosed.
“This transaction reflects a strategic move to consolidate digital infrastructure assets,” said AIFA spokesperson Emily Chen. “Our focus remains on legal compliance and ensuring transparency for all stakeholders.”
Legal and Regulatory Implications
AIFA warned it would pursue legal action against “false information” that “distorts market perceptions or harms investor interests.” The company reiterated that all shareholder agreements are tied to HyalRoute’s official registry, which it claims validates the deal’s legitimacy.
Regulatory filings show the transaction is subject to approval by the U.S. Securities and Exchange Commission (SEC) and other oversight bodies. AIFA has not yet commented on potential delays or challenges.
Market Reaction and Investor Caution
Shares of AIFA closed flat on June 13, 2026, amid uncertainty. Analysts at RBC Capital Markets noted the dispute could impact investor confidence, particularly if the allegations gain traction. “While AIFA has strong legal backing, prolonged uncertainty may affect valuation,” wrote analyst Michael Torres.
Investors are advised to refer to official AIFA filings and avoid relying on unverified media reports. The company urged stakeholders to “consult authoritative sources” for updates.
Keep reading